Insmed (INSM)
Insmed News
Insmed Provides Corporate Update; Projects Cash Sufficient to Generate Top-Line Data from Three Priority Studies
Benzinga about 3 hours agoInsmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE In Patients With Non-tuberculous Mycobacterial Lung Disease
Benzinga about 7 days agoInsmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease
PR Newswire about 7 days agoMONMOUTH JUNCTION, N.J., May 23, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that it has begun screening patients for its U.S. phase 2 clinical ...
INSMED INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
about 13 days agoInPlay: Insmed appoints Donald J. Hayden, Jr. as Executive Chairman
about 14 days agoInsmed Appoints Donald J. Hayden, Jr. as Executive Chairman
Benzinga about 14 days agoINSMED INC Financials
about 18 days agoINSMED INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
about 21 days agoNew Star Analyst Rankings for Insmed, Inc.
about 21 days agoInsmed Inc. Earnings: Loss Narrows and Tops Forecasts
about 22 days agoInsmed Incorporated Earnings Call scheduled for 8:30 am ET today
about 22 days agoINSMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
about 22 days agoQ1 2012 Insmed Incorporated Earnings Release - Before Market Open
about 22 days agoYou may also be interested in these INSM related companies
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| INSM | 2.95 | -0.02 | -0.67% | 73.83M |
| INSD | 39.03 | +0.00 | +0.00% | |
| INS | 1.64 | +0.00 | +0.00% | 14.69M |
| INPH | 4.79 | -0.17 | -3.43% | 34.27M |
| INOD | 5.44 | -0.12 | -2.16% | 137.28M |
| INOC | 1.32 | +0.00 | +0.00% | 17.17M |
| INO | 0.44 | -0.01 | -2.22% | 59.39M |
| ININ | 25.90 | -0.26 | -0.99% | 500.44M |
| ING | 5.79 | -0.26 | -4.30% | 22.88B |
| IMN | 5.63 | -0.05 | -0.88% | 217.71M |
